Effects of lianhuang decoction in treating fetomaternal ABO blood group incompatibility / 中国中西医结合杂志
Chinese Journal of Integrated Traditional and Western Medicine
;
(12): 156-158, 2009.
Artículo
en Chino
| WPRIM
| ID: wpr-337527
ABSTRACT
<p><b>OBJECTIVE</b>To investigate the clinical curative effect of Lianhuang Decoction (LHD) in treating fetomaternal ABO blood group incompatibility (FM-ABOI).</p><p><b>METHODS</b>Sixty pregnancy women diagnosed as FM-ABOI were randomly assigned to two groups, Group A treated with LHD and Group B treated with Western medicine. The therapeutic efficacy in the two groups was observed.</p><p><b>RESULTS</b>The antibody titer decreased after treatment in both groups to different extent; the effective rate was 90.0% in Group A and 56.7% in Group B. The bilirubin level in cord blood of Group A was lower than that in Group B significantly (P<0.01). No statistically significant difference was found between the two groups new-bom in terms of 5-minute Apgar score, body weight and hemoglobin content in cord blood (P>0.05).</p><p><b>CONCLUSION</b>LHD has good clinical curative effect in treating FM-ABOI, could decrease the serum antibody titer, and prevent the occurrence of postpartum hemolytic disease in newborns.</p>
Texto completo:
Disponible
Índice:
WPRIM (Pacífico Occidental)
Asunto principal:
Incompatibilidad de Grupos Sanguíneos
/
Sistema del Grupo Sanguíneo ABO
/
Medicamentos Herbarios Chinos
/
Usos Terapéuticos
/
Quimioterapia
/
Ictericia Neonatal
/
Fitoterapia
Límite:
Adulto
/
Femenino
/
Humanos
/
Recién Nacido
/
Embarazo
Idioma:
Chino
Revista:
Chinese Journal of Integrated Traditional and Western Medicine
Año:
2009
Tipo del documento:
Artículo
Similares
MEDLINE
...
LILACS
LIS